ATNM: David Matthew T reports a stock award
By AlphaYouPublished Form 4
David Matthew T
Reporting filer
David Matthew T reports a stock award, not an open-market purchase or sale, in Actinium Pharmaceuticals, Inc.. Form 4 filed Oct 16, 2026 lists 2 entries.
- Disclosed
- Oct 16, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | David Matthew T | 2026-10-14 | A | Grant or award | 250000 | 0 | 250,000 | 2 days | Filed terms
|
| Stock Option (right to purchase) (derivative) | David Matthew T | 2026-10-14 | A | Grant or award | 250000 | 0 | 250,000 | 2 days | Filed terms
|
Common Stock
- Owner
- David Matthew T
- Date
- 2026-10-14
- Code
- A
- Action
- Grant or award
- Quantity
- 250000
- Price
- 0
- Following holdings
- 250,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- id: F1
- transaction Date: 2026-10-14
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 250000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 250000
- direct Or Indirect Ownership: D
Stock Option (right to purchase) (derivative)
- Owner
- David Matthew T
- Date
- 2026-10-14
- Code
- A
- Action
- Grant or award
- Quantity
- 250000
- Price
- 0
- Following holdings
- 250,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to purchase)
- id: F2
- conversion Or Exercise Price: 0.9750
- transaction Date: 2026-10-14
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 250000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- expiration Date: 2036-10-14
- underlying Security Title: Common Stock
- underlying Security Shares: 250000
- shares Owned Following Transaction: 250000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- David Matthew T: Chief Financial Officer.
- F1: On October 14, 2026 (the "Grant Date"), Mr. David was granted two hundred fifty thousand (250,000) Restricted Stock Units ("RSUs") under the Actinium Pharmaceuticals, Inc. 2026 Employment Inducement Award Plan (the "Inducement Plan"). One hundred twenty-five thousand (125,000) RSUs shall vest in three (3) equal installments on each of the first, second, and third anniversaries of the Grant Date, subject to Mr. David's continuing service to the Issuer on each the applicable vesting date. One hundred twenty-five thousand (125,000) RSUs shall vest in full on the third (3rd) anniversary of the Grant Date, subject to Mr. David's continuing service to the Issuer on the applicable vesting date.
- F2: On the Grant Date, Mr. David was granted the option to purchase 250,000 shares of common stock (the "Option Grant") of Actinium Pharmaceuticals, Inc. (the "Issuer") under the Inducement Plan.
- F3: Twenty-eight percent (28%) of the Option Grant shall vest twelve (12) months after the Grant Date and two percent (2%) of the Option Grant shall vest each month thereafter, subject to Mr. David's continuing service to the Issuer on each application vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.